drugset

drugset / Trial / NCT00408954

Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms

NCT00408954 ↗

Phase 2 Completed 27 enrolled Pfizer

RandomizedCrossoverTriple-blindTreatment

Summary

This is a pilot study to generate hypotheses about the urodynamic effects of UK-369,003 in men with lower urinary tract symptoms.

Timeline

Start: 2007-03
Primary completion: 2008-06
Completion: 2008-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	GISADENAFIL	Small molecule	100 mg	—

Indications